Rhön-Klinikum AG

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: DE0007042301
EUR
12.40
-4.12 (-24.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.86 k

Shareholding (Sep 2018)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.72%

  • Poor long term growth as Net Sales has grown by an annual rate of 4.45% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.00
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

EUR 830 Million ()

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.32%

stock-summary
Debt Equity

-0.00

stock-summary
Return on Equity

3.05%

stock-summary
Price to Book

0.63

Revenue and Profits:
Net Sales:
419 Million
(Quarterly Results - Jun 2025)
Net Profit:
7 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-29.3%
0%
-29.3%
6 Months
-32.46%
0%
-32.46%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Rhön-Klinikum AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.53%
EBIT Growth (5y)
17.72%
EBIT to Interest (avg)
1.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
1.04
Tax Ratio
20.54%
Dividend Payout Ratio
15.44%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
1.54%
ROE (avg)
1.72%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.60
EV to EBIT
12.29
EV to EBITDA
5.33
EV to Capital Employed
0.53
EV to Sales
0.35
PEG Ratio
2.55
Dividend Yield
0.34%
ROCE (Latest)
4.30%
ROE (Latest)
3.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2018stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 6.65% vs 13.89% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -21.28% vs 62.07% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "418.80",
          "val2": "392.70",
          "chgp": "6.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.00",
          "val2": "23.90",
          "chgp": "0.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.40",
          "val2": "9.40",
          "chgp": "-21.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.90%",
          "val2": "21.90%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.23% vs 2.49% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.44% vs 49.44% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,826.90",
          "val2": "1,672.50",
          "chgp": "9.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.10",
          "val2": "45.70",
          "chgp": "62.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "3.70",
          "chgp": "-16.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.70",
          "val2": "1.90",
          "chgp": "-294.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.20",
          "val2": "40.20",
          "chgp": "12.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.30%",
          "val2": "-11.60%",
          "chgp": "1.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
418.80
392.70
6.65%
Operating Profit (PBDIT) excl Other Income
24.00
23.90
0.42%
Interest
0.80
0.80
Exceptional Items
0.10
-0.00
Consolidate Net Profit
7.40
9.40
-21.28%
Operating Profit Margin (Excl OI)
21.90%
21.90%
NA
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 6.65% vs 13.89% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -21.28% vs 62.07% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,826.90
1,672.50
9.23%
Operating Profit (PBDIT) excl Other Income
74.10
45.70
62.14%
Interest
3.10
3.70
-16.22%
Exceptional Items
-3.70
1.90
-294.74%
Consolidate Net Profit
45.20
40.20
12.44%
Operating Profit Margin (Excl OI)
6.30%
-11.60%
1.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 9.23% vs 2.49% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 12.44% vs 49.44% in Dec 2023

stock-summaryCompany CV
About Rhön-Klinikum AG stock-summary
stock-summary
Rhön-Klinikum AG
Hospital
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available